1. Home
  2. WTO vs BRTX Comparison

WTO vs BRTX Comparison

Compare WTO & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$2.47

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.31

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
BRTX
Founded
2008
1997
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.9M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
WTO
BRTX
Price
$2.47
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.2K
6.5M
Earning Date
08-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.08
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
N/A
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.19
52 Week High
$4.50
$2.10

Technical Indicators

Market Signals
Indicator
WTO
BRTX
Relative Strength Index (RSI) 44.87 43.81
Support Level $0.63 $0.19
Resistance Level $3.77 $1.18
Average True Range (ATR) 0.27 0.03
MACD -0.15 0.03
Stochastic Oscillator 0.01 97.71

Price Performance

Historical Comparison
WTO
BRTX

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: